Journals / Türk Anestezi ve Reanimasyon Dergisi / 2003 / Cilt: 31 - Sayı: 5

Peroperative phenol entoxication during chemical dermabrasion

Kimyasal dermabrazyon sırasında peroperatif fenol entoksikasyonu

Pages
253–257
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We concluded that, the toxicity developed in our case might be due to phenol administration in a wide suface area for short time period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Xeroderma Pigmentosum is a rare disease characterized by dermal keratosis, hyperpigmentation and a group of dermal malignancy.
📊
Key Findings & Data:In our case; our patient has undergone tarsoraphy and chemical dermabrasion had been applied over % 10 of total body surface with phenol for an hour because of xeroderma pigmentosum.
💡
Conclusion & Impact:We concluded that, the toxicity developed in our case might be due to phenol administration in a wide suface area for short time period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Xeroderma Pigmentosum is a rare disease characterized by dermal keratosis, hyperpigmentation and a group of dermal malignancy. For the treatment of malign or premalign dermal lesions either surgical or chemical dermabrasion are available methods. Phenol, despite its widespread use in plastic and reconstructive surgery in higher concentrations for chemical dermabrasion; toxic reactions with its minimal concentrations has been reported. In our case; our patient has undergone tarsoraphy and chemical dermabrasion had been applied over % 10 of total body surface with phenol for an hour because of xeroderma pigmentosum. A sudden onset ventricular tachycardia ending for aproximately 5 hours later had started. Serum LDH and AST levels were above limits for 3 days, serum CK-MB levels were above limits for 6 days. By the end of 6 days; our patient has been discharged with normal physical and neurological examination signs and with normal laboratuar findings. It has been reported in the literature that, the determinants of phenol intoxication include the concentration of phenol solution, application time interval, application area and the degree of perfusion in the area of phenol application. We concluded that, the toxicity developed in our case might be due to phenol administration in a wide suface area for short time period.

Özet

Kseroderma pigmentozum, dermal keratoz, pigmentasyon artışı ve çeşitli tipte cilt kanserleri ile kendini gösteren, nadir görülen bir hastalıktır. Tedavisinde malign ve premalign cilt lezyonlarının cerrahi eksizyonu yada kimyasal dermabrazyon uygulanabilir. Fenol, kimyasal dermabrazyon amacı ile plastik ve rekonstrüktif cerrahide, yüksek konsantrasyonlarda yaygın olarak kullanılmasına rağmen, çok düşük konsantrasyonları ile toksik reaksiyonların gelişebildiği bildirilmektedir. Olgumuza, kseroderma pigmentozum nedeni ile tarsorafi ve vücut yüzey alanının ortalama % 10 kadarına, bir saatlik süre içinde fenol ile kimyasal dermabrazyon uygulanmış; uygulamanın sonunda, ani başlayan 5 saat kadar süren ventriküler taşikardi, 3 gün serum LDH (Laktik Dehidrogenaz) ve AST (Aspartat Aminot-ransferaz) yüksekliği, 6 gün serum CK-MB (Kreatin Kinaz Kalp dokusu izoenzimi) yüksekliği gelişmiş, daha sonra normal fizik-nörolojik muayene ve laboratuar bulguları ile taburcu edilmiştir. Literatürde fenol entoksikasyonu gelişmesinde, fenol konsantrasyonu, uygulama süresi, uygulama alanı ve uygulama alanının perfüzyonunun etkili olabileceğine dair bilgilere rastlanmaktadır. Olgumuzda kısa sürede geniş yüzey alanına uygulanan fenolün toksisiteden sorumlu olabileceği düşünülmüştür.

🔖

Cite This Article

ERDOĞAN, G., ERK, G., DİKMEN, B., ÜNLÜ, E. (2022). Peroperative phenol entoxication during chemical dermabrasion. Türk Anestezi ve Reanimasyon Dergisi, Cilt: 31 - Sayı: 5, 253–257. https://ajindex.com/articles/620221

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Stal S, Spira M: Basal and squamous cell carcinoma of the skin. Aston SJ, Beasley RW, Thorne CHM. In: Grabb's and Smith's Plastic Surgery. 5th Ed. Lippincott-Raven Publishers, Philadelphia 1997; p.l 12
  2. Orlowv SJ: Benign growths and generalized skin disorders. Aston SJ, Beasley RW, Thome CHM. In: Grabb's and Smith's Plastic Surgery. 5th Ed. Lippincott-Raven Publishers, Philadelphia, 1997; p. 151
  3. Woo DF: Phenol and related compounds. Olson KR. In: Poisoning and drug overdose 3th. Ed. Connecticut Appleton and Lange 1994; 255-57
  4. Akan İM, Özdemir R, Sungur N, et al: Combined treatment of xeroderma pigmentosum with full-face chemical peeling and dermabrasion. EurJ Plast Surg 2001; 24:243-46
  5. Baker TJ: Chemical face peeling and rhytideclomy. Plast Reconst Surg 1962; 29(2):199-207
  6. Baker TJ: The voice of polite dissent: Major electrocardio-graphic changes during chemical face peeling. Plast Reconst Surg 1979; 63:262
  7. Gross BG: Cardiac arrhytmias during phenol face peeling. Plast Reconst Surg 1984; 73(4):59D-94
  8. Litton C: Observations after cbemosurgery of the face. Plast Reconst Surg 1963; 32(5):554-6
  9. Truppman ES, Ellenby JD: Major electrocardiographic changes during chemical face peeling. Plast and Reconst Surg 1979; 63:44-8
  10. Spiller HA, Quadrani-Kushner DA, Cleveland P: A five year evaluation of acute exposure to phenol disinfectant (% 26). Clinical Toxicology, 1993; 31(2):307-13, 11. Forrest T, Rumage DTO: Cardiac dysrhtmia after subtrigonal phenol. Anaesthesia, 1987; 42:777-78
  11. Wexier MR, Halon DA, Tietelbaum A: The prevention of cardiac arrhytmias produced İn an animal model by the topical application of a phenol preparation in common use for face peeling. Plast Reconst Surg 1984; 73(4):595-8
  12. Zamponi GW, French RS: Arrhythmias during phenol therapies: A specific action on cardiac sodium channels? Circulation 1994; 9(2):914
  13. Morgan GE, Mikhail MS: Hepalic physiology and anesthesia In: Clinical anesthesiology 2nd. Ed. Stamfort Appleton and Lange 1996; p.611-24
  14. Alexander RW, Oratt CM, Roberts R: Diagnosis and management of patients with acute myocardial infarction In: Alexander RW, Schlant RC, Fuster V. Hurst's the heart. Vol. 19th. Ed. USA McGraw Hill Companies. 1998; p.1354-61.